We just received data on a new analyst forecast for $ZTS. Piper Sandler gave a rating of 'Overweight' for $ZTS.
$ZTS Analyst Ratings
Wall Street analysts have issued reports on $ZTS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- Barclays issued a "Overweight" rating on 02/14/2025
- Morgan Stanley issued a "Overweight" rating on 02/14/2025
To track analyst ratings and price targets for $ZTS, check out Quiver Quantitative's $ZTS forecast page.
$ZTS Price Targets
Multiple analysts have issued price targets for $ZTS recently. We have seen 6 analysts offer price targets for $ZTS in the last 6 months, with a median target of $192.5.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $215.0 on 08/11/2025
- Daniel Clark from Leerink Partners set a target price of $155.0 on 07/17/2025
- Jonathan Block from Stifel set a target price of $160.0 on 06/18/2025
- Andrea Alfonso from UBS set a target price of $170.0 on 05/07/2025
- Balaji Prasad from Barclays set a target price of $244.0 on 02/14/2025
- Erin Wright from Morgan Stanley set a target price of $238.0 on 02/14/2025
$ZTS Congressional Stock Trading
Members of Congress have traded $ZTS stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ZTS stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 05/15 and 2 sales worth up to $30,000 on 04/08, 02/25.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $100,000 on 05/13 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 4 times. They made 2 purchases worth up to $100,000 on 04/07, 03/05 and 2 sales worth up to $100,000 on 05/12, 04/17.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/01, 03/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ZTS Insider Trading Activity
$ZTS insiders have traded $ZTS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ZTS stock by insiders over the last 6 months:
- ROXANNE LAGANO (Executive Vice President) has made 0 purchases and 3 sales selling 1,304 shares for an estimated $222,064.
- WILLIE M REED sold 1,210 shares for an estimated $201,029
- KRISTIN C PECK (Chief Executive Officer) sold 382 shares for an estimated $59,852
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZTS Hedge Fund Activity
We have seen 851 institutional investors add shares of $ZTS stock to their portfolio, and 906 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF AMERICA CORP /DE/ removed 4,167,351 shares (-36.2%) from their portfolio in Q1 2025, for an estimated $686,154,342
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,308,177 shares (-99.3%) from their portfolio in Q1 2025, for an estimated $544,691,343
- CAPITAL WORLD INVESTORS removed 2,592,319 shares (-39.5%) from their portfolio in Q1 2025, for an estimated $426,825,323
- FUNDSMITH LLP added 2,319,158 shares (+1020.2%) to their portfolio in Q1 2025, for an estimated $381,849,364
- MITSUBISHI UFJ ASSET MANAGEMENT CO., LTD. added 1,995,491 shares (+113.0%) to their portfolio in Q2 2025, for an estimated $311,196,821
- MACKENZIE FINANCIAL CORP added 1,782,110 shares (+4158.3%) to their portfolio in Q1 2025, for an estimated $293,424,411
- GAMMA INVESTING LLC removed 1,746,667 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $272,392,718
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
